Baricitinib is an oral Janus kinase ( JAK )1/ JAK 2 inhibitor approved for the treatment of
rheumatoid arthritis ( RA ) that was independently predicted, using artificial intelligence ( AI ) …

Human cytomegalovirus (HCMV), a ubiquitous human pathogen, is the leading cause of birth
defects and morbidity in immunocompromised patients and a potential trigger for vascular …

Human cytomegalovirus (HCMV) is a widely circulating pathogen that causes severe disease
in immunocompromised patients and infected fetuses. By immortalizing memory B cells …

Background Monitoring the adaptive immune responses during the natural course of severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection provides useful …

A panel of human sera exhibited a ≥128-fold higher neutralizing potency against a human
cytomegalovirus (HCMV) clinical isolate propagated and tested in endothelial (or epithelial) …

Mutations that occurred during adaptation of human cytomegalovirus to cell culture were
monitored by isolating four strains from clinical samples, passaging them in various cell types …

In the winter–spring seasons 2003–2004 and 2004–2005, 47 (5.7%) patients with acute
respiratory infection associated with human coronavirus (hCoV) 229E‐, NL63‐, and OC43‐like …

Human cytomegalovirus (HCMV) was investigated in peripheral blood leukocytes (PBL) of
52 immunocompetent patients (40 pregnant women) with primary HCMV infection by …

Primary human cytomegalovirus (HCMV) infections during pregnancy are associated with a
high risk of virus transmission to the fetus. To identify correlates of intrauterine HCMV …

In the coronavirus (CoV) disease 2019 (COVID-19) pandemic, highly selective serological
testing is essential to define exposure to severe acute respiratory syndrome CoV 2 (SARS-…